AlphaMaven AlphaMaven

ARES - Ares Management Corp Stock Price and Quote

Reported by Finviz
May 27, 2026· 3 min read
Save Post LinkedIn Email
Key Takeaways
  • • ARES closed at $109.13 on June 26, 2026, down 2.97% on the day following a broad market selloff, with the stock experiencing intraday weakness amid sector-wide pressure on alternative asset managers and rising rate-hike expectations.
  • • TD Cowen raised its price target to $153 from $144 on June 23, 2026, maintaining a Buy rating and signaling analyst confidence despite near-term volatility, with a one-year consensus target of $145.76.
  • • Ares trades at a trailing P/E of 50.29 with a forward P/E of 17.86, reflecting significant valuation compression and a PEG ratio of 0.89, suggesting growth expectations relative to earnings multiples in the near term.
  • • Market capitalization stands at approximately $36 billion (intraday) with a 52-week range of $95.80 to $195.26, indicating substantial volatility; the stock yields 4.95% on a forward dividend of $5.40 per share.
  • • TTM earnings of $2.17 per share and net income of $561.67 million demonstrate profitability, though elevated leverage (Total Debt/Equity of 1.68x) and ROE of 14.18% reflect the capital-intensive nature of alternative asset management.
Summary
Ares Management Corporation (ARES) declined 2.97% to close at $109.13 on June 26, 2026, pressured by a broad technology-led market selloff that dragged the S&P 500 down 1.44% and the Nasdaq over 2%, fueled by rising rate-hike expectations and concerns over artificial intelligence spending. The sell-off extended to alternative asset managers, consistent with sector-wide pressure affecting peers in the space. In pre-market trading, the stock recovered slightly to $109.90, up 0.80%, suggesting potential stabilization following the intraday decline.

Analyst sentiment remains constructively bullish. On June 23, 2026, TD Cowen raised its price target on ARES to $153 from $144 while maintaining a Buy rating, reflecting confidence in the company's strategic positioning and growth trajectory. The consensus one-year target stands at $145.76, implying approximately 33% upside from the June 26 closing price. Volume on the day totaled 2.59 million shares, slightly below the 30-day average of 2.98 million.

Valuation metrics reveal a premium but compressed multiple structure. The stock trades at a trailing P/E of 50.29 based on trailing twelve-month earnings of $2.17 per share, while the forward P/E of 17.86 reflects expectations for meaningful earnings growth. The PEG ratio of 0.89 suggests the valuation is reasonable relative to expected growth rates. The company's market capitalization (intraday) stands at $35.996 billion, with an enterprise value of $38.78 billion. Price-to-sales of 4.08 and enterprise value-to-revenue of 6.56 align with premium alternative asset manager valuations.

Financial fundamentals demonstrate solid operational performance. Ares generated $5.91 billion in trailing twelve-month revenue with net income available to common shareholders of $561.67 million, translating to a profit margin of 10.54%. Return on equity reached 14.18% (TTM), while return on assets was 2.54%, reflecting efficient capital deployment within the constraint of the asset-light business model. The company maintains $1.44 billion in cash (most recent quarter) against total debt representing 168% of equity, a leverage profile consistent with alternative asset managers utilizing debt to enhance returns.

The forward dividend of $5.40 per share yields 4.95%, offering institutional investors a material income component alongside capital appreciation potential. The 52-week trading range of $95.80 to $195.26 underscores volatility characteristic of the alternative asset management sector, with beta of 1.52 indicating above-market sensitivity to broader equity moves. Next earnings release is estimated for July 30, 2026.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Finviz ARES - Ares Management Corp Stock Price and Quote